Found 17 matching trials
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET PHASE2 The purpose of the study is to evaluate the efficacy and tolerability of th...
Show More Location
Vienna General Hospital
Learn More & Join Trial
Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy PHASE2 Somatostatine induces a dose-dependent reduction of postprandial plasma cho...
Show More Location
University Hospital of Brussels
Learn More & Join Trial
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly PHASE2 The purpose of this study is to compare the effectiveness of lanreotide aut...
Show More Location
Baptist Health System Inc
Learn More & Join Trial
Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg PHASE2 This study aims to explore the efficacy and safety of lanreotide Autogel® 1...
Show More Learn More & Join Trial
Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects PHASE4 The purpose of the study is to assess the efficacy of an extended injection...
Show More Location
Universidade Federal do Rio de Janeiro - Department of Internal Medicine - Section of Endocrinology - Neuroendocrine Research Center
Learn More & Join Trial
Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients PHASE4 Circulating tumour cells (CTCs) are detectable in the blood in around 50% o...
Show More Location
Basingstoke & North Hampshire Hospital
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly PHASE3 This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Show More Location
University of Michigan
Learn More & Join Trial
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours PHASE3 This is a Phase 3, prospective, multi-center, randomized, double-blind, stu...
Show More Location
Arizona Oncology Associates
Learn More & Join Trial
Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease PHASE2 An open-label, Phase II clinical study to evaluate the efficacy and safety ...
Show More Location
UZ Leuven, Gasthuisberg
Learn More & Join Trial
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours PHASE2 To evaluate, in patients with progressive neuroendocrine tumours who are no...
Show More Learn More & Join Trial